Bunkerhill ECG-EF vs Ligence Heart
AI Verdict
Choose Bunkerhill ECG-EF if…
Choose Bunkerhill ECG-EF if your primary goal is to rapidly and non-invasively screen a broad patient population for early signs of reduced left ventricular ejection fraction (LVEF) using readily available 12-lead ECGs. This tool is ideal for identifying patients at risk for heart failure in primary care, emergency departments, or general cardiology clinics, enabling timely referral for further diagnostic workup.
View Bunkerhill ECG-EF →Choose Ligence Heart if…
Choose Ligence Heart if your cardiology department or imaging center seeks to significantly enhance the efficiency and accuracy of 2D transthoracic echocardiography analysis and reporting. This platform is best suited for automating complex measurements, view classifications, and report generation, thereby streamlining workflows for cardiologists and sonographers and improving diagnostic consistency.
View Ligence Heart →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Bunkerhill ECG-EF | Ligence Heart |
|---|---|---|
| Pricing | Contact sales for pricing details. | Contact-for-pricing |
| Deployment | Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. | Cloud-based; on-premise; hybrid |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Bunkerhill ECG-EFBunkerhill ECG-EF analyzes routine 12-lead ECGs, a widely available and non-invasive test, and integrates seamlessly with EHRs, suggesting a lower barrier to entry and easier adoption into existing clinical workflows. Ligence Heart, while automating echocardiography analysis, still relies on the more complex and specialized process of acquiring echocardiogram images.
Clinical Value
Ligence HeartLigence Heart automates comprehensive analysis of 2D transthoracic echocardiography, which is the gold standard for detailed cardiac structure and function assessment, offering more in-depth disease recognition and quantification for conditions like heart failure, cardiomyopathy, and valvular heart diseases. Bunkerhill ECG-EF provides valuable early identification of reduced LVEF from ECGs, but echocardiography offers a more definitive and detailed diagnostic picture.
Pricing & Value
TieBoth tools require contacting the vendor for pricing, indicating an enterprise-focused, likely custom pricing model. Without specific pricing information or details on ROI, it is impossible to compare their value directly.
Enterprise Readiness
Ligence HeartBoth tools are FDA-cleared, HIPAA compliant, and offer BAA, demonstrating strong foundational readiness. However, Ligence Heart offers more flexible deployment options (cloud, on-premise, hybrid) and integration with PACS, EHR, and RIS, which provides greater adaptability for diverse enterprise IT infrastructures and existing imaging workflows.
Innovation
Bunkerhill ECG-EFBunkerhill ECG-EF demonstrates a higher degree of innovation by deriving critical LVEF information from a routine 12-lead ECG, a test not traditionally used for direct LVEF measurement, thereby expanding diagnostic reach and accessibility. While Ligence Heart innovates by automating complex echocardiography analysis, the concept of AI-assisted image analysis is becoming more established.
Support & Docs
Ligence HeartLigence Heart explicitly mentions providing a Software Installation Manual as a separate document to the IFU, offers training videos to operators, and provides a direct support email and contact for security issues. While Bunkerhill Health's website mentions a 'Trust Center' and internal security procedures, it does not provide explicit details on product-specific support channels or documentation readily available to users.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Bunkerhill ECG-EF | Ligence Heart |
|---|---|---|
| Name | Bunkerhill ECG-EF | Ligence Heart |
| Company | BunkerHill Health | Ligence |
| Description | FDA-cleared artificial intelligence algorithm by BunkerHill Health that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure. | AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers. |
| Primary Data Input | Routine 12-lead ECG data | 2D transthoracic echocardiography imaging data |
| Key Functionality | Detects reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) | Automates analysis and reporting of echocardiography, including measurements and disease recognition |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and Ligence Heart.